Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 88INDUSTRY 4NIH 3NETWORK 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Respiratory Distress Syndrome 1Pneumonia, Viral 1Pancreatic Neoplasms 1Glioma 1Cytokine Release Syndrome 1

Interventions

Radiotherapy 299Cisplatin 263Cyclophosphamide 229Doxorubicin 176Paclitaxel 167Vincristine 160Carboplatin 150Filgrastim 139Etoposide 139Gemcitabine 118Fluorouracil 113Docetaxel 112Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 91Leucovorin 90Granulocyte Colony-Stimulating Factor 74Specimen Handling 66Magnetic Resonance Spectroscopy 62Capecitabine 59Irinotecan 58Radiation 54Ifosfamide 51Oxaliplatin 48Daunorubicin 48Temozolomide 47Radiotherapy, Conformal 47Platinum 47Peripheral Blood Stem Cell Transplantation 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Interventional × Hydroxychloroquine × Clear all
NCT05518110 2026-04-13

PaTcH

Cancer Trials Ireland

Phase 2 Terminated
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04201457 2026-02-03

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

Pediatric Brain Tumor Consortium

Phase 1/2 Active not recruiting
57 enrolled
CNS

Glioma

NCT04394182 2022-03-29

ULTRA-COVID

Fundacion GenesisCare

Phase NA Suspended
15 enrolled

Cytokine Release Syndrome, Pneumonia, Viral, Respiratory Distress Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡